Ledger.Open graph →
SEC Form D · filed July 15, 2016

Helocyte, Inc

Offering
$5.0M
Sold
$1.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Frank Taffy · New York, NYExec · DirectorDavid J. Horin · New York, NYExecMichael S. Weiss · New York, NYDirectorKenneth W. Cappell · New York, NYDirectorLindsay A. Rosenwald · New York, NYDirectorElizabeth C. Moore · New York, NYExecKhaled Beydoun · New York, NYDirectorJeffrey Dachis · New York, NYDirectorSteve Traxler · Chicago, ILDirectorCary Marr · New York, NYExec · DirectorStuart Ellman · New York, NYExecKaren W. Bryant · Seattle, WAExecJohn S. Struck · Hamilton, BermudaDirectorOlaf Carlson-Wee · Danville, CAExecEthan Kay · Irvine, CADirectorKarl O'Reilly · New York, NYExecJames W. Judson · Seattle, WAExec · DirectorBrian J. Friedman · Cos Cob, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗